VTRS.OQ
Latest Trade
13.91USDChange
0.32(+2.35%)Volume
3,553,748Today's Range
-
13.9952 Week Range
-
19.24As of on the NASDAQ ∙ Minimum 15 minute delay
Previous Close | 13.59 |
---|---|
Open | 13.69 |
Volume | 3,553,748 |
3M AVG Volume | 243.31 |
Today's High | 13.99 |
Today's Low | 13.36 |
52 Week High | 19.24 |
52 Week Low | 12.76 |
Shares Out (MIL) | 1,207.08 |
Market Cap (MIL) | 16,790.52 |
Forward P/E | 3.77 |
Dividend (Yield %) | -- |
Viatris Inc. Announces 2021 Financial Guidance And Reaffirms Strategic And Financial Commitments
Biocon Biologics Gets Deferred FDA Action On License Application For Avastin Biosimilar
Viatris Recommends Caution On Trc Capital's Attempt To Acquire Shares At Significant Discount Via Mini-Tender Offer
Viatris Inc., formerly Upjohn Inc., is a healthcare company. It is a scientific, manufacturing and distribution company that is specialized in delivering medicines to patients in over 165 countries and territories. It provides access to medicines, advance sustainable operations, develop solutions and leverage it's specializatiin to connect people to products and services through it's Global Healthcare Gateway. It's portfolio comprises of more than 1,400 molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, global brands, complex generic and branded medicines, portfolio of biosimilars and a variety of over-the-counter consumer products. It produces medicines for patients across a broad range of therapeutic areas, spanning both noncommunicable and infectious diseases, which include cardiovascular, oncology, immunology, women’s healthcare, diabetes and metabolism, gastroenterology, respiratory and allergy and dermatology.
Industry
Biotechnology & Drugs
Contact Info
1000 Mylan Boulevard
CANONSBURG, PA
15317
United States
+1.724.5141465
https://www.viatris.com/Price To Earnings (TTM) | -- |
---|---|
Price To Sales (TTM) | 1.41 |
Price To Book (MRQ) | 0.73 |
Price To Cash Flow (TTM) | 13.70 |
Total Debt To Equity (MRQ) | 112.34 |
LT Debt To Equity (MRQ) | 97.71 |
Return on Investment (TTM) | -1.75 |
Return on Equity (TTM) | -1.44 |
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.